Apr 19,2023 Press Release Predictmedix Introduces Ground-breaking Technology for Cardiovascular Risk Management: Safe Entry Stations Now Measure Blood Pressure, Heart Rate Variability and Blood Oxygen Non-Invasively
Mar 30,2023 Press Release Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations
Mar 28,2023 Press Release Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application
Mar 23,2023 Press Release Predictmedix Expands on Non-Invasive AI-powered Impairment Detection Technology for Vertical-Specific Applications
Mar 21,2023 Press Release Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
Mar 15,2023 Press Release Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Mar 08,2023 Press Release Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia
Mar 06,2023 Press Release Predictmedix Announces a Purchase Order for Safe Entry’s Fit for Duty Screening in the Defence Sector
Feb 15,2023 Press Release Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare
Feb 13,2023 Press Release Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange
